ANX 188 Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC): A phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial of ANX-188 injection in Children with Sickle Cell disease experienci

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/136/30/16

Funding

  • Mast Therapeutics, Inc.